Showing results (271-280 of 427) with videos related to
Sort By:
Pageof 43
Cancer Prevention Research (Philadelphia, Pa.)|November 9, 2018
Obesity-associated Breast Inflammation among Hispanic/Latina Breast Cancer PatientsHeather Greenlee, Zaixing Shi, Hanina Hibshoosh, et al.Cancer|April 21, 2012
Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancerPatrick G Morris, Gary A Ulaner, Anne Eaton, et al.Cancer Prevention Research (Philadelphia, Pa.)|February 28, 2015
Menopause is a determinant of breast adipose inflammationNeil M Iyengar, Patrick G Morris, Xi Kathy Zhou, et al.Clinical Breast Cancer|December 31, 2005
The global breast cancer burden: variations in epidemiology and survivalGabriel N Hortobagyi, Jaime de la Garza Salazar, Kathleen Pritchard, et al.Journal of the American Geriatrics Society|June 17, 2006
Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal studyArti Hurria, Carol Rosen, Clifford Hudis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation studyShanu Modi, Alison T Stopeck, Michael S Gordon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2014
Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused updateHarold J Burstein, Sarah Temin, Holly Anderson, et al.The New England Journal of Medicine|May 25, 2002
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutationNoah D Kauff, Jaya M Satagopan, Mark E Robson, et al.Clinical Breast Cancer|April 23, 2018
Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast CancerPatrick G Morris, Selene Rota, Karen Cadoo, et al.British Journal of Cancer|August 14, 2014
EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trialH Cheng, K Ballman, M Vassilakopoulou, et al.Pageof 43